FITZGERALD, Ga., Feb. 21, 2018 -- Colony Bankcorp, Inc. (Nasdaq:CBAN) announced today that its Board of Directors declared a quarterly cash dividend of $0.05 per share payable March 30, 2018 to shareholders of record on March 5, 2018. The board factored in earnings projected for the quarter along with Colony’s capital position in setting the dividend payment. Colony’s capital position remains strong with its total risk-based capital approximating 15.56 percent – well above the regulatory minimum requirement of 10 percent to be categorized as “well-capitalized.”
Colony Bankcorp, Inc. is a bank holding company headquartered in Fitzgerald, Georgia with twenty-eight offices located in central, southern and coastal Georgia cities of Albany, Ashburn, Broxton, Centerville, Columbus, Cordele, Douglas, Eastman, Fitzgerald, Leesburg, Moultrie, Quitman, Rochelle, Savannah, Soperton, Statesboro, Sylvester, Thomaston, Tifton, Valdosta and Warner Robins, Georgia. Total consolidated assets of the company approximate $1.20 billion.
Colony Bankcorp, Inc. Common Stock is quoted on the Nasdaq National Market under the symbol “CBAN.”
Contact:
Terry L. Hester
Chief Financial Officer
Colony Bankcorp, Inc.
Fitzgerald, GA 31750
(229) 426-6000 (ext. 6002)


Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Amazon Explores AI Content Marketplace With Media Publishers
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 



